Search Results 581-590 of 17793 for Lipid
The purpose of this study is to compare weight loss, improvement of comorbidities, improvement of lipid profile, blood sugar in patients undergoing ...
... lipid lowering medications; Provide informed written consent; Willing to return to enrolling institution for follow-up (during the active monitoring phase of ...
Mayo Clinic researchers are committed to improving the understanding, diagnosis and management of liver fibrosis. Mayo researchers were among the first to ...
... lipid screening in individuals over 40 years of age who have a 10-year risk of atherosclerotic cardiovascular disease that is greater than 10%—may not ...
... lipid, or muscle disease. Clinically significant abnormal laboratory result at Screening in the opinion of the Investigator, including but not limited to ...
Inclisiran injection is used together with a proper diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in patients with ...
Participation eligibility · Individuals with abnormal blood tests of lipids or biomarkers of liver and kidney dysfunction. · Individuals who are smokers or having ...
... lipid lowering medication, and/or current cigarette smoker; Patients with significant hearing loss are not eligible for study participation defined as ...
... Lipid Lowering (IDEAL) study (0.05% vs 0.02%, p = 0.625) or the Treating to New Targets (TNT) trial (0.0% vs 0.04%, p = 0.500) trial. Results were similar ...
Dyslipidemia – Triglycerides > 250 mg/dl or cholesterol > 220 mg/dl or HDL < 35 mg/dl or LDL > 200 or use of lipid lowering medications. Sleep Apnea – A ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.